{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 10, "total": 52798 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "10005428", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "2", "companynumb": "US-ASTRAZENECA-2013SE85964", "duplicate": "1", "reportduplicate": { "duplicatesource": "ASTRAZENECA", "duplicatenumb": "US-ASTRAZENECA-2013SE85964" }, "primarysource": { "reportercountry": "US", "qualification": "1" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Eczema", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "CASODEX", "drugauthorizationnumb": "020498", "drugdosagetext": "DAILY", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugindication": "PROSTATIC SPECIFIC ANTIGEN INCREASED", "drugstartdateformat": "602", "drugstartdate": "2013", "actiondrug": "4", "openfda": { "application_number": [ "NDA020498" ], "brand_name": [ "CASODEX" ], "generic_name": [ "BICALUTAMIDE" ], "manufacturer_name": [ "ANI Pharmaceuticals, Inc." ], "product_ndc": [ "62559-680" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "BICALUTAMIDE" ], "rxcui": [ "108828", "199123" ], "spl_id": [ "9395c6cd-8f49-423e-839b-0c3aeb89b371" ], "spl_set_id": [ "dfee4fe7-8478-4a3e-925d-00be3cd0ab67" ], "package_ndc": [ "62559-680-30" ], "nui": [ "N0000000243", "N0000175560" ], "pharm_class_moa": [ "Androgen Receptor Antagonists [MoA]" ], "pharm_class_epc": [ "Androgen Receptor Inhibitor [EPC]" ], "unii": [ "A0Z3NAU9DP" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ELIGARD", "drugdosagetext": "UNKNOWN Q4MONTHS", "drugadministrationroute": "050", "drugindication": "PROSTATE CANCER", "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } } ] } }, { "safetyreportversion": "1", "safetyreportid": "10011223", "primarysourcecountry": "FR", "occurcountry": "FR", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "2", "serious": "1", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20140314", "receiptdateformat": "102", "receiptdate": "20140314", "fulfillexpeditecriteria": "1", "companynumb": "FR-SA-2014SA030778", "duplicate": "1", "reportduplicate": { "duplicatesource": "AVENTIS", "duplicatenumb": "FR-SA-2014SA030778" }, "primarysource": { "reportercountry": "FR", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "63", "patientonsetageunit": "801", "patientweight": "80", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Malignant melanoma", "reactionoutcome": "3" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "ELIGARD", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "021731", "drugstructuredosagenumb": "45", "drugstructuredosageunit": "003", "drugadministrationroute": "058", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20120711", "drugenddateformat": "102", "drugenddate": "20130709", "actiondrug": "5", "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } } ] } }, { "safetyreportversion": "3", "safetyreportid": "10013537", "primarysourcecountry": "AT", "occurcountry": "AT", "transmissiondateformat": "102", "transmissiondate": "20150528", "reporttype": "1", "serious": "1", "seriousnesshospitalization": "1", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20140314", "receiptdateformat": "102", "receiptdate": "20141001", "fulfillexpeditecriteria": "1", "companynumb": "AT-AMGEN-AUTSP2014017182", "duplicate": "1", "reportduplicate": { "duplicatesource": "AMGEN", "duplicatenumb": "AT-AMGEN-AUTSP2014017182" }, "primarysource": { "reportercountry": "AT", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "73", "patientonsetageunit": "801", "patientagegroup": "6", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "18.0", "reactionmeddrapt": "Osteonecrosis of jaw", "reactionoutcome": "1" } ], "drug": [ { "drugcharacterization": "2", "medicinalproduct": "CALCIDURAN" }, { "drugcharacterization": "1", "medicinalproduct": "XGEVA", "drugauthorizationnumb": "125320", "drugstructuredosagenumb": "120", "drugstructuredosageunit": "003", "drugdosagetext": "120 MG, Q4WK", "drugadministrationroute": "058", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "610", "drugstartdate": "201203", "actiondrug": "5", "activesubstance": { "activesubstancename": "DENOSUMAB" }, "openfda": { "application_number": [ "BLA125320" ], "brand_name": [ "XGEVA" ], "generic_name": [ "DENOSUMAB" ], "manufacturer_name": [ "Amgen, Inc" ], "product_ndc": [ "55513-730" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "substance_name": [ "DENOSUMAB" ], "rxcui": [ "1046398", "1046402" ], "spl_id": [ "3ce47aaf-105d-4615-9320-1f378a9d8d84" ], "spl_set_id": [ "628f0998-1206-4001-aeee-18133aa9f3bf" ], "package_ndc": [ "55513-730-01", "55513-730-21" ], "nui": [ "N0000187055", "N0000187054" ], "pharm_class_epc": [ "RANK Ligand Inhibitor [EPC]" ], "pharm_class_moa": [ "RANK Ligand Blocking Activity [MoA]" ], "unii": [ "4EQZ6YO2HI" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ELIGARD", "drugstructuredosagenumb": "22.5", "drugstructuredosageunit": "003", "drugdosagetext": "22.5 MG, UNK", "drugstartdateformat": "102", "drugstartdate": "20120627", "activesubstance": { "activesubstancename": "LEUPROLIDE ACETATE" }, "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } } ], "summary": { "narrativeincludeclinical": "CASE EVENT DATE: 20121201" } } }, { "safetyreportversion": "1", "safetyreportid": "10014576", "primarysourcecountry": "CA", "occurcountry": "CA", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "1", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20140317", "receiptdateformat": "102", "receiptdate": "20140317", "fulfillexpeditecriteria": "1", "companynumb": "CA-SA-2014SA030809", "duplicate": "1", "reportduplicate": { "duplicatesource": "AVENTIS", "duplicatenumb": "CA-SA-2014SA030809" }, "primarysource": { "reportercountry": "CA", "qualification": "3" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "85", "patientonsetageunit": "801", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Palliative care", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "ELIGARD", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "021379", "drugstructuredosagenumb": "30", "drugstructuredosageunit": "003", "drugdosagetext": "FREQUENCY- EVERY 4 MONTHS", "drugdosageform": "INJECTION", "drugadministrationroute": "065", "drugindication": "PROSTATE CANCER", "drugstartdateformat": "102", "drugstartdate": "20090423", "drugenddateformat": "102", "drugenddate": "20131203", "actiondrug": "5", "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } } ] } }, { "safetyreportversion": "1", "safetyreportid": "10017906", "primarysourcecountry": "FR", "occurcountry": "FR", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "1", "seriousnesshospitalization": "1", "receivedateformat": "102", "receivedate": "20140318", "receiptdateformat": "102", "receiptdate": "20140318", "fulfillexpeditecriteria": "1", "companynumb": "FR-ASTRAZENECA-2014SE18246", "duplicate": "1", "reportduplicate": { "duplicatesource": "ASTRAZENECA", "duplicatenumb": "FR-ASTRAZENECA-2014SE18246" }, "primarysource": { "reportercountry": "FR", "qualification": "1" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "85", "patientonsetageunit": "801", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Renal failure acute", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Aphthous stomatitis", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Malnutrition", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Dehydration", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Pemphigoid", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Scab", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Anaemia", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Pruritus", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Rash maculo-papular", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "CASODEX", "drugauthorizationnumb": "20498", "drugdosageform": "TABLET", "drugadministrationroute": "048", "drugindication": "PROSTATE CANCER", "drugstartdateformat": "102", "drugstartdate": "20130917", "drugenddateformat": "610", "drugenddate": "201312", "openfda": { "application_number": [ "NDA020498" ], "brand_name": [ "CASODEX" ], "generic_name": [ "BICALUTAMIDE" ], "manufacturer_name": [ "ANI Pharmaceuticals, Inc." ], "product_ndc": [ "62559-680" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "BICALUTAMIDE" ], "rxcui": [ "108828", "199123" ], "spl_id": [ "9395c6cd-8f49-423e-839b-0c3aeb89b371" ], "spl_set_id": [ "dfee4fe7-8478-4a3e-925d-00be3cd0ab67" ], "package_ndc": [ "62559-680-30" ], "nui": [ "N0000000243", "N0000175560" ], "pharm_class_moa": [ "Androgen Receptor Antagonists [MoA]" ], "pharm_class_epc": [ "Androgen Receptor Inhibitor [EPC]" ], "unii": [ "A0Z3NAU9DP" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FIRMAGON", "drugadministrationroute": "058", "drugindication": "PROSTATE CANCER", "drugstartdateformat": "610", "drugstartdate": "201207", "drugenddateformat": "102", "drugenddate": "20130702", "actiondrug": "1", "openfda": { "application_number": [ "NDA022201" ], "brand_name": [ "FIRMAGON" ], "generic_name": [ "DEGARELIX" ], "manufacturer_name": [ "Ferring Pharmaceuticals Inc." ], "product_ndc": [ "55566-8303", "55566-8403" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "rxcui": [ "828749", "828751", "858125", "858127" ], "spl_id": [ "4c6e7e6f-aadd-45b1-baed-970b24766bf3" ], "spl_set_id": [ "ab11dd8a-0fd9-4013-89ab-e114557c7e4b" ], "package_ndc": [ "55566-8403-1", "55566-8303-1" ] } }, { "drugcharacterization": "1", "medicinalproduct": "XGEVA", "drugstructuredosagenumb": "120", "drugstructuredosageunit": "003", "drugadministrationroute": "058", "drugindication": "PROSTATE CANCER", "drugstartdateformat": "102", "drugstartdate": "20130930", "drugenddateformat": "610", "drugenddate": "201312", "openfda": { "application_number": [ "BLA125320" ], "brand_name": [ "XGEVA" ], "generic_name": [ "DENOSUMAB" ], "manufacturer_name": [ "Amgen, Inc" ], "product_ndc": [ "55513-730" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "substance_name": [ "DENOSUMAB" ], "rxcui": [ "1046398", "1046402" ], "spl_id": [ "3ce47aaf-105d-4615-9320-1f378a9d8d84" ], "spl_set_id": [ "628f0998-1206-4001-aeee-18133aa9f3bf" ], "package_ndc": [ "55513-730-01", "55513-730-21" ], "nui": [ "N0000187055", "N0000187054" ], "pharm_class_epc": [ "RANK Ligand Inhibitor [EPC]" ], "pharm_class_moa": [ "RANK Ligand Blocking Activity [MoA]" ], "unii": [ "4EQZ6YO2HI" ] } }, { "drugcharacterization": "1", "medicinalproduct": "VAXIGRIP", "drugstructuredosagenumb": "1", "drugstructuredosageunit": "032", "drugadministrationroute": "051", "drugindication": "INFLUENZA IMMUNISATION", "drugstartdateformat": "610", "drugstartdate": "201310", "drugenddateformat": "610", "drugenddate": "201310" }, { "drugcharacterization": "1", "medicinalproduct": "ELIGARD", "drugadministrationroute": "058", "drugindication": "PROSTATE CANCER", "drugstartdateformat": "102", "drugstartdate": "20130917", "actiondrug": "5", "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } } ] } }, { "safetyreportversion": "1", "safetyreportid": "10027033", "primarysourcecountry": "FR", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "1", "seriousnesshospitalization": "1", "receivedateformat": "102", "receivedate": "20140318", "receiptdateformat": "102", "receiptdate": "20140318", "fulfillexpeditecriteria": "1", "companynumb": "FR-014943", "duplicate": "1", "reportduplicate": { "duplicatesource": "FERRING", "duplicatenumb": "FR-014943" }, "primarysource": { "reportercountry": "FR", "qualification": "3" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "85", "patientonsetageunit": "801", "patientsex": "0", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Toxic skin eruption" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Renal failure acute" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Anaemia" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Dehydration" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Malnutrition" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Pemphigoid" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Aphthous stomatitis" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "FIRMAGON", "drugauthorizationnumb": "022201", "drugadministrationroute": "058", "drugindication": "PROSTATE CANCER METASTATIC", "drugstartdateformat": "610", "drugstartdate": "201207", "drugenddateformat": "102", "drugenddate": "20130702", "openfda": { "application_number": [ "NDA022201" ], "brand_name": [ "FIRMAGON" ], "generic_name": [ "DEGARELIX" ], "manufacturer_name": [ "Ferring Pharmaceuticals Inc." ], "product_ndc": [ "55566-8303", "55566-8403" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "rxcui": [ "828749", "828751", "858125", "858127" ], "spl_id": [ "4c6e7e6f-aadd-45b1-baed-970b24766bf3" ], "spl_set_id": [ "ab11dd8a-0fd9-4013-89ab-e114557c7e4b" ], "package_ndc": [ "55566-8403-1", "55566-8303-1" ] } }, { "drugcharacterization": "1", "medicinalproduct": "ELIGARD", "drugadministrationroute": "058", "drugindication": "PROSTATE CANCER METASTATIC", "drugstartdateformat": "102", "drugstartdate": "20130917", "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } }, { "drugcharacterization": "1", "medicinalproduct": "CASODEX", "drugadministrationroute": "048", "drugindication": "PROSTATE CANCER METASTATIC", "drugstartdateformat": "102", "drugstartdate": "20130917", "drugenddateformat": "610", "drugenddate": "201312", "openfda": { "application_number": [ "NDA020498" ], "brand_name": [ "CASODEX" ], "generic_name": [ "BICALUTAMIDE" ], "manufacturer_name": [ "ANI Pharmaceuticals, Inc." ], "product_ndc": [ "62559-680" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "BICALUTAMIDE" ], "rxcui": [ "108828", "199123" ], "spl_id": [ "9395c6cd-8f49-423e-839b-0c3aeb89b371" ], "spl_set_id": [ "dfee4fe7-8478-4a3e-925d-00be3cd0ab67" ], "package_ndc": [ "62559-680-30" ], "nui": [ "N0000000243", "N0000175560" ], "pharm_class_moa": [ "Androgen Receptor Antagonists [MoA]" ], "pharm_class_epc": [ "Androgen Receptor Inhibitor [EPC]" ], "unii": [ "A0Z3NAU9DP" ] } }, { "drugcharacterization": "1", "medicinalproduct": "XGEVA", "drugadministrationroute": "058", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20130930", "drugenddateformat": "610", "drugenddate": "201312", "openfda": { "application_number": [ "BLA125320" ], "brand_name": [ "XGEVA" ], "generic_name": [ "DENOSUMAB" ], "manufacturer_name": [ "Amgen, Inc" ], "product_ndc": [ "55513-730" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "substance_name": [ "DENOSUMAB" ], "rxcui": [ "1046398", "1046402" ], "spl_id": [ "3ce47aaf-105d-4615-9320-1f378a9d8d84" ], "spl_set_id": [ "628f0998-1206-4001-aeee-18133aa9f3bf" ], "package_ndc": [ "55513-730-01", "55513-730-21" ], "nui": [ "N0000187055", "N0000187054" ], "pharm_class_epc": [ "RANK Ligand Inhibitor [EPC]" ], "pharm_class_moa": [ "RANK Ligand Blocking Activity [MoA]" ], "unii": [ "4EQZ6YO2HI" ] } }, { "drugcharacterization": "1", "medicinalproduct": "VAXIGRIP", "drugstructuredosagenumb": "1", "drugstructuredosageunit": "032", "drugadministrationroute": "051", "drugindication": "INFLUENZA IMMUNISATION", "drugstartdateformat": "610", "drugstartdate": "201310", "drugenddateformat": "610", "drugenddate": "201310" } ] } }, { "safetyreportversion": "2", "safetyreportid": "10028083", "primarysourcecountry": "CA", "occurcountry": "CA", "transmissiondateformat": "102", "transmissiondate": "20141212", "reporttype": "1", "serious": "1", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20140321", "receiptdateformat": "102", "receiptdate": "20140401", "fulfillexpeditecriteria": "1", "companynumb": "CA-SA-2014SA032176", "duplicate": "1", "reportduplicate": { "duplicatesource": "AVENTIS", "duplicatenumb": "CA-SA-2014SA032176" }, "primarysource": { "reportercountry": "CA", "qualification": "1" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "85", "patientonsetageunit": "801", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Metastases to bone", "reactionoutcome": "3" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "ELIGARD", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "021731", "drugdosagetext": "DOSE=45MG/6ML", "drugdosageform": "INJECTION", "drugadministrationroute": "042", "drugindication": "PROSTATE CANCER", "drugstartdateformat": "102", "drugstartdate": "20090505", "actiondrug": "4", "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } } ] } }, { "safetyreportversion": "3", "safetyreportid": "10041151", "primarysourcecountry": "CA", "occurcountry": "CA", "transmissiondateformat": "102", "transmissiondate": "20141212", "reporttype": "1", "serious": "1", "seriousnesshospitalization": "1", "receivedateformat": "102", "receivedate": "20140327", "receiptdateformat": "102", "receiptdate": "20140418", "fulfillexpeditecriteria": "1", "companynumb": "CA-SA-2014SA033879", "duplicate": "1", "reportduplicate": { "duplicatesource": "AVENTIS", "duplicatenumb": "CA-SA-2014SA033879" }, "primarysource": { "reportercountry": "CA", "qualification": "3" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "89", "patientonsetageunit": "801", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Hospitalisation", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Drug dose omission", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "ELIGARD", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "021379", "drugstructuredosagenumb": "22.5", "drugstructuredosageunit": "003", "drugdosagetext": "FREQUENCY- Q3 MONTHS", "drugdosageform": "INJECTION", "drugadministrationroute": "058", "drugindication": "PROSTATE CANCER", "drugstartdateformat": "102", "drugstartdate": "20131219", "actiondrug": "4", "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } }, { "drugcharacterization": "1", "medicinalproduct": "ELIGARD", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "021379", "drugstructuredosagenumb": "22.5", "drugstructuredosageunit": "003", "drugdosagetext": "FREQUENCY: Q 3 MONTHS", "drugdosageform": "INJECTION", "drugadministrationroute": "058", "drugindication": "PROSTATE CANCER", "actiondrug": "4", "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } } ] } }, { "safetyreportversion": "1", "safetyreportid": "10047055", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "1", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20140331", "receiptdateformat": "102", "receiptdate": "20140331", "fulfillexpeditecriteria": "2", "companynumb": "US-MYLANLABS-2013S1003961", "duplicate": "1", "reportduplicate": { "duplicatesource": "MYLAN", "duplicatenumb": "US-MYLANLABS-2013S1003961" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "84", "patientonsetageunit": "801", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Diarrhoea", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Vomiting", "reactionoutcome": "1" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "FENTANYL TRANSDERMAL SYSTEM", "drugbatchnumb": "6D0072", "drugauthorizationnumb": "076258", "drugstructuredosagenumb": "25", "drugstructuredosageunit": "004", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "805", "drugdosagetext": "CHANGE Q 72 HRS", "drugdosageform": "TRANSDERMAL PATCH", "drugadministrationroute": "062", "drugindication": "CANCER PAIN", "drugstartdateformat": "102", "drugstartdate": "20130214", "actiondrug": "4" }, { "drugcharacterization": "2", "medicinalproduct": "ELIGARD", "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } } ] } }, { "safetyreportversion": "1", "safetyreportid": "10047568", "primarysourcecountry": "FR", "occurcountry": "FR", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "1", "seriousnesshospitalization": "1", "receivedateformat": "102", "receivedate": "20140331", "receiptdateformat": "102", "receiptdate": "20140331", "fulfillexpeditecriteria": "1", "companynumb": "FR-JNJFOC-20140312850", "duplicate": "1", "reportduplicate": { "duplicatesource": "JANSSEN", "duplicatenumb": "FR-JNJFOC-20140312850" }, "primarysource": { "reportercountry": "FR", "qualification": "3" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "91", "patientonsetageunit": "801", "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Renal failure acute", "reactionoutcome": "2" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Urinary retention", "reactionoutcome": "1" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "DUROGESIC", "drugdosageform": "Matrix Patch", "drugadministrationroute": "062", "drugindication": "PAIN", "drugstartdateformat": "102", "drugstartdate": "20140212", "actiondrug": "1", "drugrecurreadministration": "2" }, { "drugcharacterization": "1", "medicinalproduct": "DUROGESIC", "drugauthorizationnumb": "019813", "drugdosageform": "Matrix Patch", "drugadministrationroute": "062", "drugindication": "PAIN", "drugstartdateformat": "610", "drugstartdate": "201401", "drugenddateformat": "102", "drugenddate": "20140211", "actiondrug": "1", "drugrecurreadministration": "2" }, { "drugcharacterization": "1", "medicinalproduct": "RISPERDAL", "drugauthorizationnumb": "020272", "drugstructuredosagenumb": ".5", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosageform": "TABLETS", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugenddateformat": "102", "drugenddate": "20140214", "actiondrug": "1", "drugrecurreadministration": "2", "openfda": { "application_number": [ "NDA020272", "NDA020588" ], "brand_name": [ "RISPERDAL" ], "generic_name": [ "RISPERIDONE" ], "manufacturer_name": [ "Janssen Pharmaceuticals, Inc." ], "product_ndc": [ "50458-300", "50458-302", "50458-320", "50458-330", "50458-350", "50458-395", "50458-315", "50458-325", "50458-335", "50458-355", "50458-305" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "RISPERIDONE" ], "rxcui": [ "104781", "104782", "104783", "104784", "199387", "211489", "262222", "312829", "312830", "312831", "312832", "314211", "401953", "401954", "403825", "616698", "616705", "630890", "630974", "806297", "806298", "806299" ], "spl_id": [ "408e48a3-35fc-49e1-8e01-44305d9083a4" ], "spl_set_id": [ "7e117c7e-02fc-4343-92a1-230061dfc5e0" ], "package_ndc": [ "50458-302-06", "50458-302-50", "50458-302-01", "50458-300-06", "50458-300-50", "50458-300-01", "50458-320-06", "50458-320-50", "50458-320-01", "50458-330-06", "50458-330-50", "50458-330-01", "50458-350-06", "50458-350-01", "50458-395-28", "50458-395-30", "50458-315-28", "50458-315-30", "50458-325-28", "50458-335-28", "50458-355-28", "50458-305-03" ], "nui": [ "N0000175430" ], "pharm_class_epc": [ "Atypical Antipsychotic [EPC]" ], "unii": [ "L6UH7ZF8HC" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ELIGARD", "drugstructuredosagenumb": "22.5", "drugstructuredosageunit": "003", "drugdosageform": "SOLUTION FOR INJECTION", "drugadministrationroute": "058", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "openfda": { "application_number": [ "NDA021379", "NDA021488", "NDA021731", "NDA021343" ], "brand_name": [ "ELIGARD" ], "generic_name": [ "LEUPROLIDE ACETATE" ], "manufacturer_name": [ "TOLMAR Inc." ], "product_ndc": [ "62935-223", "62935-753", "62935-303", "62935-453", "62935-227", "62935-756", "62935-306", "62935-461" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "rxcui": [ "752884", "752889", "752894", "752899", "825325", "825333", "825334", "825335" ], "spl_id": [ "2bea4c81-66a2-4817-9440-5f5da8dea04a", "58cff066-4345-4624-8868-4c232a051a5d" ], "spl_set_id": [ "b78d1919-9dee-44fa-90f9-e0a26d32481d", "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc" ], "package_ndc": [ "62935-753-75", "62935-754-74", "62935-755-75", "62935-223-05", "62935-221-04", "62935-224-05", "62935-303-30", "62935-305-29", "62935-304-30", "62935-453-45", "62935-454-44", "62935-455-45", "62935-756-80", "62935-306-40", "62935-227-10", "62935-461-50" ], "substance_name": [ "LEUPROLIDE ACETATE" ], "unii": [ "37JNS02E7V" ] } }, { "drugcharacterization": "2", "medicinalproduct": "LACTULOSE", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosageform": "Unspecified", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "openfda": { "application_number": [ "ANDA074603", "ANDA217914", "ANDA207786", "ANDA209517", "ANDA218858", "ANDA075911", "ANDA074623", "ANDA074712", "ANDA090503", "ANDA075993", "ANDA203762", "ANDA090502" ], "brand_name": [ "GENERLAC", "LACTULOSE", "KRISTALOSE", "CONSTULOSE", "LACTULOSE CRYSTALLINE", "ENULOSE" ], "generic_name": [ "LACTULOSE" ], "manufacturer_name": [ "Chartwell RX, LLC", "PAI Holdings, LLC dba PAI Pharma", "APOZEAL PHARMACEUTICALS INC", "Sun Pharmaceutical Industries, Inc.", "Xttrium Laboratories, Inc.", "Cumberland Pharmaceuticals Inc.", "Actavis Pharma, Inc.", "Lannett Company, Inc.", "Chartwell RX, LLC.", "Trifluent Pharma, Inc.", "Cumberland Assured Products Inc.", "Chartwell Governmental & Specialty RX, LLC.", "Fresenius Kabi Austria GmbH", "Foxland Pharmaceuticals, Inc." ], "product_ndc": [ "62135-892", "0121-0965", "0121-1930", "83745-405", "62135-002", "62135-004", "51672-4243", "0116-4005", "0121-1154", "0121-0577", "0121-4577", "66220-719", "66220-729", "45963-439", "0527-5125", "62135-003", "83745-249", "73352-900", "73352-905", "85592-819", "85592-829", "68999-002", "68999-004", "45963-438", "0121-1746", "0121-0873", "18124-002", "69067-010", "69067-020" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL", "RECTAL" ], "substance_name": [ "LACTULOSE" ], "rxcui": [ "391937", "544455", "1251190", "1251194", "1251192", "1251196", "544452", "755470" ], "spl_id": [ "1d600b06-58c7-b83e-e063-6294a90a86f9", "78330d1b-d8d8-46ab-afcd-3a6362520db6", "da3c87b0-6781-4c58-83ca-1839cf914333", "49798265-6d70-8bc1-e063-6394a90a59d4", "3b8ff35a-8b5e-7aca-e063-6394a90aea34", "4f6f0368-4b59-a9df-e063-6294a90ae43c", "6843c997-c52c-4978-b087-647f7c3fa782", "85528d56-e38f-4565-9136-c7639b479634", "7fd63ff0-fccd-408a-9c56-2c2fefdb74fc", "1b869904-b3c5-4f81-a333-1f26b6b2c7bf", "456e6761-40f8-db90-e063-6394a90a2393", "2341cf95-5e57-47ab-9dc3-73afa86b786d", "3eaf2342-fb58-e0a5-e063-6394a90a7271", "ef4e6e26-7b7d-4c48-8cc8-c101cc24d6f9", "437b8b21-3264-1b6c-e063-6294a90a1d51", "bda4ccaa-fa33-4911-b3bd-12391c365f47", "b73c2ddc-a690-46e1-aa89-40fa890c9ab4", "d95ab755-1c2e-4124-8ed7-075936257c25", "4618824a-2b40-3d54-e063-6394a90a4b96" ], "spl_set_id": [ "35207edd-a5fe-4369-a079-7a8b0d2f2e91", "5ae4b6da-44df-419a-9f2b-8c4d79f635c8", "72ac130a-de85-464d-9e9b-05cac0c54db1", "d6975cd8-80e0-43e2-809a-175ea7e40715", "391cfd01-c1fa-41f9-abd7-d0abe9a27634", "df62ad54-5aba-4d05-e053-2a95a90aa48d", "0f19e4ed-c90a-4330-a7fa-bf911aa98f09", "535dd1ea-b567-49f7-9a84-8ea91e78c466", "461ec39f-eeb4-4460-9b5c-62367d47162b", "6619b25c-26b7-4c43-8c4f-9d33a23c61ca", "bd9f1577-65e8-4521-b176-e5fc60a4a018", "a8af7389-3699-4873-b05a-509af7e8eaab", "3eaf273a-b49d-2595-e063-6394a90a1cf6", "59e75426-42ae-4904-941f-009181101a8a", "887157ba-3c91-4fbf-bb12-b49c6fa4252c", "00c42c5c-d19e-4130-aa08-a8bbd47d3e5b", "cbf0497c-9c8d-4dfa-bebd-64c589468401", "a89835c9-8ce5-4627-8d7d-70ff175b2e07", "3363bdbd-f0d1-45b3-8193-7fdb0a310cc2" ], "package_ndc": [ "62135-892-47", "62135-892-94", "0121-0965-01", "0121-0965-30", "0121-1930-01", "0121-1930-30", "83745-405-16", "83745-405-32", "62135-002-37", "62135-002-47", "62135-002-94", "62135-002-78", "62135-002-51", "62135-002-24", "62135-004-43", "62135-004-24", "51672-4243-9", "0116-4005-08", "0116-4005-16", "0116-4005-32", "0116-4005-15", "0116-4005-40", "0116-4005-10", "0116-4005-30", "0116-4005-41", "0116-4005-11", "0121-0577-16", "0121-4577-15", "0121-4577-40", "0121-4577-06", "0121-4577-50", "0121-1154-30", "0121-1154-40", "0121-1154-06", "0121-1154-00", "66220-719-01", "66220-719-30", "66220-729-01", "66220-729-30", "45963-439-63", "45963-439-65", "0527-5125-68", "0527-5125-70", "0527-5125-78", "0527-5125-82", "62135-003-37", "62135-003-47", "62135-003-94", "62135-003-78", "83745-249-08", "83745-249-16", "83745-249-32", "73352-900-01", "73352-900-15", "73352-905-01", "73352-905-15", "85592-819-01", "85592-819-30", "85592-829-01", "85592-829-30", "68999-002-51", "68999-002-24", "68999-004-43", "68999-004-24", "45963-438-64", "0121-0873-08", "0121-0873-16", "0121-0873-32", "0121-0873-15", "0121-1746-30", "0121-1746-40", "0121-1746-00", "0121-1746-06", "18124-002-16", "69067-020-15", "69067-010-15" ], "nui": [ "N0000175811", "N0000010288", "N0000175833", "N0000009871" ], "pharm_class_epc": [ "Osmotic Laxative [EPC]" ], "pharm_class_moa": [ "Osmotic Activity [MoA]", "Acidifying Activity [MoA]" ], "pharm_class_pe": [ "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]" ], "unii": [ "9U7D5QH5AE" ] } }, { "drugcharacterization": "2", "medicinalproduct": "MODOPAR", "drugstructuredosagenumb": "62.5", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "3", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "50MG/12.5MG", "drugdosageform": "Capsules", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION" }, { "drugcharacterization": "2", "medicinalproduct": "SEROPLEX", "drugstructuredosagenumb": "5", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosageform": "TABLETS", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION" }, { "drugcharacterization": "2", "medicinalproduct": "VITAMINE B12", "drugstructuredosagenumb": "1", "drugstructuredosageunit": "032", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "802", "drugdosageform": "Unspecified", "drugadministrationroute": "030", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION" }, { "drugcharacterization": "2", "medicinalproduct": "XATRAL LP", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosageform": "TABLETS", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION" } ] } } ] }